Bastide Le Confort Médical SA (EPA:BLC)
France · Delayed Price · Currency is EUR 23.00
+0.30 (1.32%)
Aug 21, 2026, 5:35 PM CET
EPA:BLC Income Statement
Financials in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 510.46 | 491.18 | 461.87 | 508.03 | 468.3 | 444.07 | |
Revenue Growth | 16.56% | 6.35% | -9.09% | 8.48% | 5.46% | 16.04% |
Cost of Revenue | 166.47 | 158.18 | 153.25 | 174.3 | 161.5 | 163.81 |
Gross Profit | 344 | 333 | 308.63 | 333.73 | 306.8 | 280.26 |
Selling, General & Admin | 230.71 | 225.82 | 212.34 | 229.68 | 207.42 | 188.96 |
Amortization of Goodwill & Intangibles | 59.03 | 59.03 | 55.01 | 58.8 | - | - |
Other Operating Expenses | 3.61 | 2.96 | 2.75 | 2.43 | 4.4 | 3.01 |
Operating Expenses | 296.23 | 287.81 | 270.11 | 290.91 | 267.87 | 242.76 |
Operating Income | 47.77 | 45.19 | 38.52 | 42.82 | 38.93 | 37.5 |
Interest Expense | -27.3 | -30.84 | -26.88 | -16.59 | -10.2 | -8.91 |
Earnings From Equity Investments | 0.03 | 0.03 | - | 0.04 | 0.01 | - |
Other Non Operating Income (Expenses) | -0.01 | 2.19 | 5.31 | 2.66 | -1.34 | 0.77 |
EBT Excluding Unusual Items | 20.49 | 16.56 | 16.94 | 28.93 | 27.4 | 29.37 |
Merger & Restructuring Charges | 0.72 | 0.13 | -0.68 | - | -1.85 | -1.37 |
Asset Writedown | -2.49 | -0.96 | 0.75 | -0.03 | -0.04 | -0.52 |
Legal Settlements | -1.08 | -3.16 | - | - | -1.33 | -0.54 |
Other Unusual Items | -3.29 | -2.03 | -3.9 | -6.13 | -3.17 | -6.77 |
Pretax Income | 14.35 | 10.54 | 13.12 | 22.77 | 21.02 | 20.17 |
Income Tax Expense | 3.95 | 6.49 | 6.61 | 5.96 | 5.93 | 5.82 |
Earnings From Continuing Operations | 10.41 | 4.05 | 6.51 | 16.81 | 15.09 | 14.35 |
Earnings From Discontinued Operations | 19.61 | -2.49 | -5.3 | -4.02 | -0.76 | - |
Net Income to Company | 30.02 | 1.56 | 1.21 | 12.79 | 14.33 | 14.35 |
Minority Interest in Earnings | -0.55 | -1.03 | -2.11 | -0.74 | -0.65 | -0.9 |
Net Income | 29.47 | 0.53 | -0.9 | 12.05 | 13.68 | 13.45 |
Net Income to Common | 29.47 | 0.53 | -0.9 | 12.05 | 13.68 | 13.45 |
Net Income Growth | 1652.26% | - | - | -11.94% | 1.70% | 15.97% |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 7 | 7 |
Shares Change | 2.95% | -0.04% | 0.04% | 7.66% | 0.22% | 0.03% |
EPS (Basic) | 3.94 | 0.07 | -0.12 | 1.62 | 1.86 | 1.83 |
EPS (Diluted) | 3.61 | 0.07 | -0.11 | 1.52 | 1.86 | 1.83 |
EPS Growth | 1576.94% | - | - | -18.28% | 1.64% | 15.90% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | 55.46 | 41.74 | 24.46 | 52.05 | 3.59 | 27.85 |
Free Cash Flow Per Share | 6.78 | 5.26 | 3.08 | 6.56 | 0.49 | 3.79 |
Dividend Per Share | - | - | - | - | - | 0.270 |
Dividend Growth | - | - | - | - | - | 0% |
Gross Margin | 67.39% | 67.80% | 66.82% | 65.69% | 65.51% | 63.11% |
Operating Margin | 9.36% | 9.20% | 8.34% | 8.43% | 8.31% | 8.45% |
Profit Margin | 5.77% | 0.11% | -0.19% | 2.37% | 2.92% | 3.03% |
Free Cash Flow Margin | 10.86% | 8.50% | 5.29% | 10.24% | 0.77% | 6.27% |
EBITDA | 86.56 | 83.08 | 75.16 | 82.93 | 79.51 | 72.77 |
EBITDA Margin | 16.96% | 16.91% | 16.27% | 16.32% | 16.98% | 16.39% |
D&A For EBITDA | 38.8 | 37.89 | 36.65 | 40.11 | 40.58 | 35.27 |
EBIT | 47.77 | 45.19 | 38.52 | 42.82 | 38.93 | 37.5 |
EBIT Margin | 9.36% | 9.20% | 8.34% | 8.43% | 8.31% | 8.45% |
Effective Tax Rate | 27.48% | 61.60% | 50.40% | 26.18% | 28.21% | 28.87% |